Crystallization is a defining unit operation in small molecule development because it directly shapes solid form, particle size distribution, morphology, filterability, and downstream manufacturability. For pharmaceutical and biotech teams, an underperforming crystallization step can lead to unstable polymorphs, inconsistent isolation, poor powder handling, and avoidable scale-up risk. BOC Sciences provides end-to-end crystallization services tailored to drug substance development, from early solid form exploration to robust process optimization for reproducible API isolation. Our team designs science-driven crystallization strategies that integrate supersaturation control, solvent system selection, seeding, cooling and anti-solvent profiles, crystal habit tuning, and isolation planning to help clients achieve the desired crystalline form, improve product quality, and support efficient development progression.
We design and optimize crystallization workflows for APIs and key intermediates, building robust processes around solubility behavior, supersaturation control, impurity rejection, and target crystal attributes.
Our crystallization scientists combine process understanding with polymorph screening and solid form screening and selection strategies to guide projects toward stable and manufacturable forms.
We provide targeted recrystallization services to enhance purity while preserving yield and controlling crystal properties, especially for compounds with challenging impurity profiles.
We translate lab-scale crystallization understanding into scalable process knowledge by addressing mixing, heat transfer, seeding behavior, and particle attribute control from the start.
BOC Sciences helps you control crystal form, purity, morphology, and scalability through practical crystallization development strategies tailored to your molecule.
We investigate solvent effects, saturation profiles, metastable zone width, and temperature-dependent solubility to establish a rational foundation for crystallization process design and troubleshooting.
Controlled seeding strategies enable us to guide nucleation events, narrow particle size distribution, reduce spontaneous batch-to-batch variation, and improve crystal growth reproducibility.
We use orthogonal solid-state tools, including XRD testing, to confirm crystal form, monitor phase behavior, and evaluate crystallization outcomes with high confidence.
Our team develops cooling, evaporative, and anti-solvent crystallization methods that balance yield, purity, and crystal quality while minimizing uncontrolled precipitation and oiling out.
Crystallization is evaluated together with downstream isolation so that crystal size, habit, and slurry properties support efficient filtration, washing, and drying rather than create bottlenecks later.
For candidates moving toward formulation, we connect crystallization outputs with pre-formulation screening and downstream developability considerations such as flow, compressibility, and dissolution behavior.
BOC Sciences supports crystallization development across a broad range of pharmaceutical molecules and process contexts. Whether you need early solid form understanding or a more production-ready isolation strategy, we tailor the workflow to the material profile, development stage, and technical objectives of the project.
Share your compound profile, current isolation issue, or target crystal attributes. Our scientists will design a tailored crystallization development plan aligned with your project goals.
We begin by reviewing molecular structure, solubility tendencies, impurity context, prior process observations, and the client's target outcomes for crystal form, yield, purity, and particle attributes.
Our team performs focused experiments to evaluate solvent systems, cooling profiles, anti-solvent addition modes, seeding conditions, and form behavior in order to identify practical development pathways.
We refine the most promising process using solid-state and particle characterization, isolating the operating window that best supports reproducible crystal quality, efficient isolation, and downstream usability.
Clients receive a clear technical package summarizing process rationale, experimental findings, crystal form outcomes, key risk points, and recommended next actions for further development or integration with formulation development.
Many development programs struggle with unexpected form conversion, hydrate formation, or inconsistent polymorphic outcomes. BOC Sciences addresses these risks by combining targeted screening, phase-aware process design, and carefully controlled crystallization conditions to steer projects toward crystal forms that are more stable, practical, and fit for downstream development.
Uncontrolled nucleation and growth frequently produce crystals that are too fine, too broad in distribution, or difficult to isolate. We optimize seeding, supersaturation trajectory, agitation, and temperature or anti-solvent profiles to improve PSD consistency and produce materials better suited for filtration, drying, and later processing steps.
Needle-like crystals, dense slurries, or fragile particles can turn a seemingly acceptable crystallization into a downstream bottleneck. Our process development strategy explicitly considers crystal habit and slurry behavior so that the final process is not only chemically effective but also operationally practical.
A crystallization that performs well at bench scale may fail when mixing, heat transfer, or seeding conditions change. We reduce scale-up uncertainty by defining robust process windows early and focusing on parameters that matter most to crystal growth behavior and solid form consistency.
From form control to isolation performance, BOC Sciences helps drug developers turn crystallization into a reliable advantage rather than a late-stage risk point.
We tailor each study to the compound's solubility, phase behavior, impurity profile, and target crystal attributes instead of relying on generic screening workflows alone.
Our team approaches crystallization as both a purification and a particle-engineering challenge, helping clients align form, morphology, and downstream processability.
We emphasize solutions that can be reproduced and transferred, with clear attention to filtration, drying, and material handling rather than isolated lab success only.
Crystallization work can be connected naturally to related BOC Sciences capabilities in solid form assessment, preformulation, and formulation-focused development support.
Client Needs: A small molecule oncology program required a more stable crystalline form after repeated batches showed form drift during isolation and storage under routine development conditions.
Challenges: The compound exhibited solvent-sensitive phase behavior and generated mixed-form material when cooling profiles were not tightly controlled. The client also needed a process that could be reproduced beyond exploratory scale.
Solution: BOC Sciences conducted targeted solvent and thermal condition mapping, followed by seeded crystallization studies focused on nucleation control and transformation suppression. We used orthogonal solid-state characterization to compare form outcomes and then established a narrowed operating window with controlled cooling and defined seed quality requirements.
Outcome: The revised process consistently delivered the desired crystalline form with improved phase consistency across repeat runs, reducing project uncertainty and enabling more confident progression into subsequent development work.
Client Needs: A respiratory development project required API crystals with a narrower particle size distribution and improved flow properties after the original crystallization process produced excessive fines and filtration delays.
Challenges: Fast spontaneous nucleation and uncontrolled anti-solvent introduction produced irregular morphology and poor slurry behavior, creating both isolation inefficiency and downstream handling issues.
Solution: We redesigned the process around staged anti-solvent addition, controlled agitation, and a structured seeding protocol. Crystal growth behavior was monitored alongside filtration performance so that process optimization balanced yield with particle quality rather than favoring either one in isolation.
Outcome: The optimized process reduced fines generation, improved cake permeability, and delivered a more development-friendly PSD range, resulting in smoother isolation and better powder handling.
Client Needs: A client developing a heteroaromatic API intermediate needed a recrystallization strategy that would remove closely related impurities without excessive product loss.
Challenges: The impurity set had similar solubility characteristics to the target compound, and early purification attempts either left residual impurities or caused unacceptable yield reduction after isolation.
Solution: BOC Sciences evaluated selective solvent combinations, temperature trajectories, and wash conditions to improve impurity partitioning. We then designed a multi-step recrystallization workflow that preserved crystal quality while enhancing purification efficiency and maintaining operational practicality.
Outcome: The final process achieved markedly improved impurity clearance with a stronger recovery profile than the client's original approach, providing a more balanced and scalable purification path.
Professional crystallization services are critical because they influence whether a compound can move smoothly from early laboratory research into a stable and scalable development stage. Crystallization is not simply a matter of making a compound precipitate; it involves solvent system selection, supersaturation control, nucleation and crystal growth behavior, solid-form tendencies, and particle property optimization. A well-designed crystallization program helps identify development risks earlier, reduces repeated experiments and process rework, and builds a stronger technical foundation for later formulation and manufacturing studies.
Crystallization development helps address major technical challenges related to solid-state behavior and process consistency in drug development. These may include poor crystal morphology, unstable particle size distribution, filtration or drying difficulties, batch-to-batch variability, and weak reproducibility across solvent systems. For development teams, the goal is not merely to obtain crystals, but to establish a crystallization process with repeatability and scale-up potential. A systematic study can also improve understanding of a compound’s physicochemical properties, leading to better development decisions and greater overall project efficiency.
Selecting the right crystallization route requires a comprehensive evaluation of solubility behavior, thermodynamic and kinetic characteristics, solvent compatibility, crystallization driving force, target crystal properties, and downstream process needs. There is rarely a universal “best” route for every molecule. Instead, the process strategy should be built on experimental evidence and tailored to the specific compound, whether that involves cooling crystallization, antisolvent crystallization, evaporative crystallization, or a combined approach. As a drug development service provider, BOC Sciences can design project-specific studies based on molecular characteristics and development goals, helping clients identify practical crystallization pathways more efficiently while reducing trial-and-error work.
Outsourcing crystallization services can help R&D teams obtain more systematic data and development insights, especially when internal resources are limited, timelines are demanding, or the target compound shows complex crystallization behavior. Experienced service providers are often able to integrate solid-form assessment, solvent screening, process development, and crystal property optimization into a unified research strategy, reducing information gaps caused by fragmented experimentation. BOC Sciences offers customized support for crystallization development within broader drug development programs, helping clients move beyond isolated experimental outcomes toward deeper process understanding and better optimization strategies, which can strengthen both project confidence and technical decision-making.
Crystallization research should begin early when a candidate compound shows clear solid-state complexity, sensitive solubility behavior, unstable crystal morphology, or scale-up issues such as filtration difficulties, variable particle properties, and limited reproducibility. Early crystallization development is also highly valuable for projects that must balance process operability with control of material attributes. In such cases, early work can significantly reduce downstream technical risk. An experienced service provider can contribute not only experimental execution but also a broader drug development perspective for prioritizing crystallization challenges. BOC Sciences can provide flexible research support based on project needs and help teams establish a more sustainable and optimization-oriented development strategy from an early stage.
BOC Sciences helped us turn a difficult polymorphic problem into a manageable development strategy. Their crystallization team identified the real source of variability and built a process we could trust.
— Dr. Martin S., Senior CMC Scientist
What stood out was not just the screening work, but their ability to connect crystallization behavior with filtration and downstream handling. That practical perspective saved us substantial redevelopment effort.
— Elena R., Director of Process Development
We needed better impurity rejection without sacrificing too much material. BOC Sciences designed a smarter recrystallization sequence and clearly explained the decision logic behind each process adjustment.
— James T., Technical Project Manager
Their work improved our particle size distribution and made isolation much easier. The combination of scientific depth and execution-focused development support made the collaboration highly productive.
— Dr. Anna K., Head of Pharmaceutical Development
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
